ARCHIVES

FDA To Issue “Complete Response” Letters To Drug Sponsors.

This article is from The Cancer Letter archive.

Vol. 34 No. 27 | July 11, 2008

Download PDF Visit The Full Archive

Related Articles

Eight CCRU, 20 CCSP Applications Submitted, Quality Is ‘Heartening’

November 19, 1982

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

NIH Describes Peer Review Process

July 12, 1996